首页> 外国专利> Process for the activating of gene-technologically produced, heterologous, disulphide bridge-containing eukaryotic proteins after expression in prokaryotes

Process for the activating of gene-technologically produced, heterologous, disulphide bridge-containing eukaryotic proteins after expression in prokaryotes

机译:在原核生物中表达后激活基因技术产生的,异源,含二硫桥的真核蛋白的方法

摘要

Method for activating non-glycosylated tissue plasminogen activator (t-PA) after its expression in prokaryotic cells comprises cell lysis; solubilisation under denaturing and reducing conditions, and reactivation under oxidising conditions in presence of reduced and oxidised glutathione (G5H, G55G). The new feature is that in the last stage is at pH 9-12 (pref. 9.5-11) with G5H and G55G concns. 0.1-20, pref. 0.2-10, mM and 0.01-3, pref. 0.5-1, mM, respectively, and with a non-denaturing concn. of the denaturing agent. Esp. the method is applied to t-PA expressed in E.coli and P. putida. The denaturing agent is pref. arginine, guanidine hydrochloride (both at 0.1-1, esp. 0.25-0.75, mM) or urea, at 0.5-4 (esp. 1-3.5) M in the last stage.
机译:在原核细胞中表达非糖基化组织纤溶酶原激活物(t-PA)后,将其激活的方法包括细胞裂解;在变性和还原条件下增溶,在还原和氧化的谷胱甘肽(G5H,G55G)存在下在氧化条件下重新活化。新功能是在最后一个阶段使用G5H和G55G浓缩液在pH 9-12(优选9.5-11)下进行。 0.1-20,首选0.2-10,mM和0.01-3,优选分别为0.5-1,mM和非变性浓度。变性剂。 Esp。该方法适用于在大肠杆菌和恶臭假单胞菌中表达的t-PA。变性剂是优选的。在最后阶段,精氨酸,盐酸胍(均为0.1-1,尤其是0.25-0.75,mM)或尿素为0.5-4(尤其是1-3.5)M。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号